Background: Placement matching guidelines are promising means to optimize patient-centered care and to match patients’ treatment needs. Despite considerable research regarding placement matching approaches to optimize alcohol abuse treatment, findings are inconclusive. Objectives: To investigate whether the use of patient-centered placement matching (PCPM) guidelines is more effective in reducing heavy drinking and costs 6 months after discharge from an inpatient alcohol withdrawal treatment compared to usual referral to aftercare. Secondary aims were to investigate whether age, gender, trial site or level of care (LOC) are moderators of efficacy and whether patients who were actually referred to the recommended LOC had better treatment outcomes compared to patients who were treated under- or overmatched. Methods:Design. Exploratory randomized controlled trial with measurements during withdrawal treatment and 6 months after initial assessment. Setting. Four German psychiatric clinics offering a 7–21 day inpatient qualified withdrawal program for patients suffering from alcohol dependence. Participants. From 1,927 patients who had a primary diagnosis of alcohol dependence and did not have organized aftercare when entering withdrawal treatment, 299 were invited to participate. Of those, 250 were randomized to the intervention group (IG, n = 123) or the control group (CG, n = 127). Intervention. The PCPM were applied to patients of the IG by feeding back a recommendation to a LOC for aftercare that was calculated from the Measurements in the Addictions for Triage and Evaluation (MATE) and discussed with the staff of the treatment unit. Patients of the CG received a general feedback regarding their MATE interview on request. Measurements. The MATE, the Client Socio-Demographic and Service Receipt Inventory--European Version and the MATE-Outcomes were administered. Data were analyzed using generalized linear models. Results: In the intention-to-treat analysis, there were no significant differences between IG and CG regarding days of heavy drinking (incident risk ratio [IRR] 1.09; p = 0.640), direct (IRR 1.06; p = 0.779), indirect (IRR 0.77; p = 0.392) and total costs (IRR 0.89; p = 0.496). Furthermore, none of the investigated moderator variables affected statistically significant drinking or cost-related primary outcomes. Regardless of group allocation, patients who received matched aftercare reported significantly fewer days of heavy drinking than undermatched patients (IRR 2.09; p = 0.004). For patients who were overmatched, direct costs were significantly higher (IRR 1.79; p = 0.024), but with no additional effects on alcohol consumption compared to matched patients. Conclusions: While the use of PCPM failed to affect the actual referral to aftercare, our findings suggest that treating patients on the recommended LOC may have the potential to reduce days of heavy drinking compared to undertreatment and costs compared to overtreatment.

1.
Rehm J, Gmel GE Sr, Gmel G, Hasan OS, Imtiaz S, Popova S, et al. The relationship between different dimensions of alcohol use and the burden of disease-an update.
Addiction
. 2017 Jun;112(6):968–1001.
2.
Levola J, Kaskela T, Holopainen A, Sabariego C, Tourunen J, Cieza A, et al. Psychosocial difficulties in alcohol dependence: a systematic review of activity limitations and participation restrictions.
Disabil Rehabil
. 2014;36(15):1227–39.
3.
Levola J, Aalto M, Holopainen A, Cieza A, Pitkänen T. Health-related quality of life in alcohol dependence: a systematic literature review with a specific focus on the role of depression and other psychopathology.
Nord J Psychiatry
. 2014 Aug;68(6):369–84.
4.
Hoffmann TC, Montori VM, Del Mar C. The connection between evidence-based medicine and shared decision making.
JAMA
. 2014 Oct;312(13):1295–6.
5.
Mee-Lee D.
ASAM patient placement criteria for the treatment of substance-related disorders
. Chevy Chase (Md.): American Society of Addiction Medicine; 2001.
6.
Merkx MJ, Schippers GM, Koeter MJ, Vuijk PJ, Oudejans S, de Vries CC, et al. Allocation of substance use disorder patients to appropriate levels of care: feasibility of matching guidelines in routine practice in Dutch treatment centres.
Addiction
. 2007 Mar;102(3):466–74.
7.
Bühringer G. Allocating treatment options to patient profiles: clinical art or science?
Addiction
. 2006 May;101(5):646–52.
8.
Schippers GM, Schramade M, Walburg JA. Reforming Dutch substance abuse treatment services.
Addict Behav
. 2002 Nov-Dec;27(6):995–1007.
9.
Sobell MB, Sobell LC. Stepped care as a heuristic approach to the treatment of alcohol problems.
J Consult Clin Psychol
. 2000 Aug;68(4):573–9.
10.
Gastfriend DR, Lu SH, Sharon E. Placement Matching: Challenges and Technical Progress.
Subst Use Misuse
. 2000 Oct-Dec;35(12-14):2191–213.
11.
Schippers GM, Broekman T, Buchholz A. MATE 2.1 Manual and Protocol. English Ed Nijmegen, Bêta Boeken, 2011.
12.
Buchholz A, Rist F, Küfner H, Kraus L. Die deutsche Version des Measurements in the Addictions for Triage and Evaluation (MATE): Reliabilität, Validität und Anwendbarkeit.
Sucht Zeitschrift für Wiss und Prax
. 2009;55(4):219–42.
13.
Schippers GM, Broekman TG, Buchholz A, Koeter MW, van den Brink W. Measurements in the Addictions for Triage and Evaluation (MATE): an instrument based on the World Health Organization family of international classifications.
Addiction
. 2010 May;105(5):862–71.
14.
Busse R, Blümel M. Germany: health system review.
Health Syst Transit
. 2014;16(2):1–296.
15.
Schulte B, Schäfer I, Reimer J. Platzierungskriterien in der Suchttherapie in Deutschland – ein Diskussionsvorschlag.
Suchttherapie
. 2003;4:3–8.
16.
Mann K, Loeber S, Croissant B, Kiefer F. Qualifizierte Entzugsbehandlung von Alkoholabhängigen: Ein Manual zur Pharmako- und Psychotherapie. Köln: Deutscher Ärzte Verlag; 2006.
17.
Schippers GM, Broekman TG, Buchholz A. MATE 2.1 Handbuch und Leitfaden. Deutsche B Nijmegen, Bêta Boeken; 2011.
18.
Röhrig J, Buchholz A, Wahl S, Berner MM. Placement matching for patients with alcohol use disorders using standardized assessment: A pilot study.
J Subst Use
. 2015;20(2):97–105.
19.
Friedrichs A, Kraus L, Berner M, Schippers GM, Broekman TG, Rist F, et al. Adaption einer niederländischen Zuweisungsleitlinie für Patienten nach qualifiziertem Alkoholentzug – Ergebnisse einer Delphi-Befragung.
Suchttherapie
. 2013;14(04):148–54.
20.
Buchholz A, Friedrichs A, Berner M, König HH, Konnopka A, Kraus L, et al. Placement matching of alcohol-dependent patients based on a standardized intake assessment: rationale and design of a randomized controlled trial.
BMC Psychiatry
. 2014 Oct;14(1):286.
21.
Buchholz A, Berner MM, Dams J, Rosahl A, Hempleman J, König HH, et al.: Patient-centered placement matching of alcohol-dependent patients based on a standardized intake assessment: process evaluation within an explorators randomized controlled trial. Addiction (submitted).
22.
StataCorp.: Stata Statistical Software: Release 12, 2011.
23.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.
JAMA
. 2013 Nov;310(20):2191–4.
24.
Sobell LC, Sobell MB, Connors GJ, Agrawal S. Assessing drinking outcomes in alcohol treatment efficacy studies: selecting a yardstick of success.
Alcohol Clin Exp Res
. 2003 Oct;27(10):1661–6.
25.
Chisholm D, Knapp MR, Knudsen HC, Amaddeo F, Gaite L, van Wijngaarden B. Client Socio-Demographic and Service Receipt Inventory–European Version: development of an instrument for international research. EPSILON Study 5. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs.
Br J Psychiatry Suppl
. 2000;177(39):s28–33.
26.
Roick C, Kilian R, Matschinger H, Bernert S, Mory C, Angermeyer MC. [German adaptation of the client sociodemographic and service receipt inventory – an instrument for the cost of mental health care].
Psychiatr Prax
. 2001 Oct;28 Suppl 2:S84–90.
27.
Bock JO, Brettschneider C, Seidl H, Bowles D, Holle R, Greiner W, et al. Ermittlung standardisierter Bewertungssätze aus gesellschaftlicher Perspektive für die gesundheitsökonomische Evaluation [Calculation of standardised unit costs form a societal perspective for health economic evaluation].
Gesundheitswesen
. 2015 Jan;77(1):53–61.
28.
Grupp H, König HH, Konnopka A. Kostensätze zur monetären Bewertung von Versorgungsleistungen bei psychischen Erkrankungen [Calculation of Standardised Unit Costs for the Economic Evaluation of Mental Disorders].
Gesundheitswesen
. 2015;79(01):48–57.
29.
Rote Liste Service GmbH. Rote Liste 2014. Arzneimittelverzeichnis für Deutschland. Frankfurt am Main: Rote Liste Service GmbH; 2014.
30.
Statistisches Bundesamt. Statistisches Jahrbuch 2013 [Statistical Year Book 2012] Wiesbaden: Statistisches Bundesamt; 2013.
31.
Schippers GM, Broekman TG, Buchholz A: MATE-Outcomes 2.1 Manual and Protocol. English Ed Nijmegen, Bêta Boeken, 2011.
32.
Dong Y, Peng CY. Principled missing data methods for researchers.
Springerplus
. 2013 May;2(1):222.
33.
Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work?
Int J Methods Psychiatr Res
. 2011 Mar;20(1):40–9.
34.
van Buuren S, Groothuis-Oudshoorn K. Mice: Multivariate Imputation by Chained Equations in R.
J Stat Softw
. 2011;45(3):1–67.
35.
IBM Corp.: IBM SPSS Statistics for Windows 2015.
36.
Günthner A, Weissinger V, Fleischmann H, Veltrup C, Jäpel B, Längle G, et al. Versorgungsorganisation – Die neue S3-Leitlinie Alkohol und ihre Bedeutung für die Versorgungspraxis Health Care Organization.
Rehabilitation (Stuttg)
. 2018;57:1–9.
37.
Deutsche Rentenversicherung (DRV), Gesetzliche Krankenversicherung (GKV), Deutsche Krankenhausgesellschaft (DKG): Handlungsempfehlungen der Deutschen Rentenversicherung (DRV), der Gesetzlichen Krankenversicherung (GKV)und der Deutschen Krankenhausgesellschaft (DKG)für die Verbesserung des Zugangs nach qualifiziertem Entzug in die medizinische Rehabilitation A. 2017.
38.
Stallvik M, Gastfriend DR. Predictive and convergent validity of the ASAM criteria software in Norway.
Addict Res Theory
. 2014;22(6):515–23.
39.
Stallvik M, Gastfriend DR, Nordahl HM. Matching patients with substance use disorder to optimal level of care with the ASAM Criteria software.
J Subst Use
. 2015;20(6):389–98.
40.
Merkx MJ, Schippers GM, Koeter MW, Vuijk PJ, Poch M, Kronemeijer H, et al. Predictive validity of treatment allocation guidelines on drinking outcome in alcohol-dependent patients.
Addict Behav
. 2013 Mar;38(3):1691–8.
41.
Verband Deutscher Rentenversicherungsträger. Vereinbarung Abhängigkeitserkrankungen 2001. Available from: http://www.suchthilfe.de/basis/vereinb_abhaengigkeitserkr5-2001.pdf.
42.
Manthey J, Laramée P, Parrott S, Rehm J. Economic burden associated with alcohol dependence in a German primary care sample: a bottom-up study.
BMC Public Health
. 2016 Aug;16(1):906.
43.
Merkx MJ, Kersten GC, Schippers GM. Indicatiestelling in de verslavingszorg: een op evidentie gebaseerde protocollaire benadering. In Buisman WR, Noorlander EA, Schippers GM, de Zwart WM (red.), Casselman J, (ed): Handboek verslaving. Houten/Zaventem, Bohn Stafleu van Loghum, 2003.
44.
Gastfriend DR, McLellan AT. Treatment matching. Theoretic basis and practical implications.
Med Clin North Am
. 1997 Jul;81(4):945–66.
45.
Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, et al. Decision aids for people facing health treatment or screening decisions.
Cochrane Database Syst Rev
. 2014 Jan;(1):CD001431.
46.
Hell ME, Miller WR, Nielsen B, Nielsen AS. Is treatment outcome improved if patients match themselves to treatment options? Study protocol for a randomized controlled trial.
Trials
. 2018 Apr;19(1):219.
47.
Merkx MJ, Schippers GM, Koeter MW, Vuijk PJ, Oudejans SC, Stam RK, et al. Guidelines for allocating outpatient alcohol abusers to levels of care: predictive validity.
Addict Behav
. 2011 Jun;36(6):570–5.
48.
Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review.
BMC Med Res Methodol
. 2006 Nov;6(1):54.
49.
Gastfriend DR. Patient-Centered Care for Opioid Use Disorders in Federally Qualified Healthcare Centers and Specialty Care Settings 2017. [cited 2018 May 15]. Available from: https://clinicaltrials.gov/ct2/show/study/NCT03367234.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.